Population
Hepatitis C virus (HCV) RNA genome internal ribosome entry site (IRES) subdomain IIa
Comparison
Benzimidazole translation inhibitor vs Unbound RNA
Design
Preclinical
Authors
Loading...
Offers a potential HCV IRES drug target; leaves open therapeutic validation in clinical models.
The discovery of a ligand-induced binding pocket in the highly conserved HCV IRES subdomain IIa provides a structural basis for developing novel anti-HCV drugs.
Dibrov et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: